ATE307588T1 - Pharmazeutische formulierung enhaltend midazolam zur buccalen verabreichung - Google Patents

Pharmazeutische formulierung enhaltend midazolam zur buccalen verabreichung

Info

Publication number
ATE307588T1
ATE307588T1 AT02258924T AT02258924T ATE307588T1 AT E307588 T1 ATE307588 T1 AT E307588T1 AT 02258924 T AT02258924 T AT 02258924T AT 02258924 T AT02258924 T AT 02258924T AT E307588 T1 ATE307588 T1 AT E307588T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulation
formulation containing
midazolam
buccal administration
containing midazolam
Prior art date
Application number
AT02258924T
Other languages
English (en)
Inventor
Graham Alan March
Original Assignee
Special Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Special Products Ltd filed Critical Special Products Ltd
Application granted granted Critical
Publication of ATE307588T1 publication Critical patent/ATE307588T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02258924T 2001-12-24 2002-12-20 Pharmazeutische formulierung enhaltend midazolam zur buccalen verabreichung ATE307588T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0130964.0A GB0130964D0 (en) 2001-12-24 2001-12-24 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE307588T1 true ATE307588T1 (de) 2005-11-15

Family

ID=9928404

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02258924T ATE307588T1 (de) 2001-12-24 2002-12-20 Pharmazeutische formulierung enhaltend midazolam zur buccalen verabreichung

Country Status (6)

Country Link
US (1) US6936605B2 (de)
EP (1) EP1323422B8 (de)
AT (1) ATE307588T1 (de)
DE (1) DE60206871T2 (de)
ES (1) ES2250594T3 (de)
GB (1) GB0130964D0 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0400804D0 (en) 2004-01-14 2004-02-18 Innoscience Technology Bv Pharmaceutical compositions
KR100755872B1 (ko) 2006-10-02 2007-09-05 충남대학교산학협력단 미다졸람을 함유하는 염증 예방 및 치료용 약제학적 조성물
US20080138383A1 (en) * 2006-12-07 2008-06-12 Jonathan David Bortz Compositions and methods for treating seizures
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
WO2010025316A1 (en) * 2008-08-29 2010-03-04 Jeffrey Comanor Composition and methods for relief of neuropathological pain
US8932645B2 (en) 2008-08-29 2015-01-13 Coastal Biologic Solutions Composition and methods for relief of chemical sensitivity
GB2481407B (en) 2010-06-22 2012-05-23 Special Products Ltd A rapid onset liquid midazolam composition for buccal administration
WO2019186515A1 (en) * 2018-03-30 2019-10-03 Ftf Pharma Private Limited Liquid pharmaceutical compositions of antiepileptic drugs
EP3886856A4 (de) * 2018-11-29 2022-01-19 Zucco Sassi Yonezawa Siviglia, Debora Verfahren zur behandlung oder vorbeugung von anfällen in zusammenhang mit einer epileptischen erkrankung
US11446262B2 (en) 2018-11-29 2022-09-20 Debora Zucco Sassi Yonezawa Siviglia Neuroquiescence—a treatment for neurodevelopmental and neurodegenerative bioelectrical dysregulation and demyelination
EP3982970A1 (de) 2019-06-12 2022-04-20 F. Hoffmann-La Roche AG Neue behandlung von sma
CN113209013B (zh) * 2021-06-24 2023-04-07 新疆特丰药业股份有限公司 一种咪达唑仑液体制剂及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6049080A (ja) * 1983-08-27 1985-03-18 Hayashibara Biochem Lab Inc 摺動部シ−ル剤
GB9717770D0 (en) 1997-08-21 1997-10-29 Scherer Ltd R P Pharmaceutical composition
US6319510B1 (en) 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
WO2001030391A2 (en) 1999-10-27 2001-05-03 Farmarc Nederland Bv Pharmaceutical composition containing midazolam

Also Published As

Publication number Publication date
US20030130267A1 (en) 2003-07-10
DE60206871T2 (de) 2006-06-08
EP1323422B8 (de) 2006-03-08
HK1057699A1 (en) 2004-04-16
EP1323422A1 (de) 2003-07-02
DE60206871D1 (de) 2005-12-01
EP1323422B1 (de) 2005-10-26
GB0130964D0 (en) 2002-02-13
ES2250594T3 (es) 2006-04-16
US6936605B2 (en) 2005-08-30

Similar Documents

Publication Publication Date Title
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
JO3404B1 (ar) تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين
US20070082041A1 (en) Topical delivery of codrugs
ATE307588T1 (de) Pharmazeutische formulierung enhaltend midazolam zur buccalen verabreichung
CY1109146T1 (el) Υγρο φαρμακευτικο σκευασμα που περιλαμβανει νικοτινη για τη χορηγηση στην στοματικη κοιλοτητα
DK1227806T3 (da) Farmaceutisk præparat indeholdende tolterodin og dets anvendelse
JP2005518354A5 (de)
HRP20050676A2 (en) Liquid pharmaceutical formulations of palonosetron
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
EP1680110A4 (de) Einmal tägliche dosierformen von trospium
ATE430564T1 (de) Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
ATE324886T1 (de) Feste arzneizusammensetzung enthaltend 4'-cyano- trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy- 2-methylpropiono- m toluidide und pvp
PL370529A1 (en) Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug
DE60214527D1 (de) Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit
ATE440838T1 (de) Pharmazeutisch aktive sulfonylaminosäurederivate
JP2005501068A (ja) 特に眼科分野における適用のための外傷および損傷の治癒および/または修復のための治療に適したアミノ酸組成物
DK1173476T3 (da) Funktionelle sojabönneproteiner
JP4746856B2 (ja) ピラゾロン系製剤
ATE243527T1 (de) Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen
ATE178208T1 (de) Capsaicin enthaltendes arzneimittel zur behandlung chronischer rhinopathie
JP3668225B2 (ja) Oct製剤
DE60331920D1 (de) Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren
ATE302010T1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
ATE446309T1 (de) Den kapillarwiderstand verbessernde peptidsubstanz, darauf basierende pharmazeutische zusammensetzung und verfahren zu deren anwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties